Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Endpoints Capital works in Biotechnology Research, out of Surry Hills, New South Wales. It is privately held, and its site is endpointscapital.com.au. It holds two addresses on record, all in Australia. Headcount on record is 5. Its work is tagged growth capital, clinical research and investment. One Australian registration (ABN) is a confirmed match. The record links seven similar brands, most of them in Investment Management.
endpointscapital.com.au LinkedIn
ABN25671248525
| ENDPOINTS CAPITAL PTY LIMITED | ABN 25671248525 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Endpoints Capital was founded to address the funding challenges that biotechnology companies face by providing a financing solution that benefits biotechs at all stages. We understand the life sciences ecosystem and the challenges - including financing - that biotech companies face getting their treatment or device into the clinic. This has been further compounded by the difficulties in capital markets in recent times.
We are excited by the opportunity to help biotechs accelerate their discovery of new medicines, therapies and life changing treatments.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One New South Wales entity on the ABR: ENDPOINTS CAPITAL PTY LIMITED (ABN 25 671 248 525), high confidence.
5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Two addresses on record, Australia only. Primary: 81-83 Campbell St, Surry Hills, New South Wales 2010.
None linked to this brand.
Five tags on the brand's own list, among them growth capital, clinical research and investment.
9 profiles list Endpoints Capital as a peer — 79th percentile in Biotechnology Research. It lists ten peers of its own. Central Pharmacy Logistics Australia and Horizon 3 Healthcare list it back.